Loading company…
ID 405104907 · FY 2018–2024 · 7 years
საქმიანობის ძირითადი მიმართულებაა მედიკამენტებით საბითუმო ვაჭრობა და მედიკამენტებთან დაკავშირებული საპრომოციო მომსახურება
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 1,313 | 1,353 | 4,339 | 871 | 1,630 | 2,090 | 3,224 | +16.2% |
| Total Non-Current Assets | 16 | 15 | 17 | 66 | 86 | 72 | 64 | +25.6% |
| TOTAL ASSETS | 1,329 | 1,368 | 4,356 | 936 | 1,715 | 2,163 | 3,287 | +16.3% |
| Total Current Liabilities | 1,005 | 1,135 | 3,562 | 58 | 354 | 197 | 73 | -35.4% |
| Total Non-Current Liabilities | 15 | 0 | 13 | 0 | 0 | 0 | 0 | -7.8% |
| TOTAL LIABILITIES | 1,020 | 1,135 | 3,575 | 58 | 354 | 197 | 73 | -35.6% |
| Total Equity | 309 | 233 | 781 | 878 | 1,362 | 1,965 | 3,215 | +47.7% |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | ||||||||
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Cash & Equivalents | 80 | 320 | 342 | 282 | 210 | 471 | 139 | +9.7% |
| Net Debt | -80 | -320 | -342 | -282 | -210 | -471 | -139 | +9.7% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).